home / stock / cort / cort quote
Last: | $22.71 |
---|---|
Change Percent: | -1.26% |
Open: | $22.87 |
Close: | $23 |
High: | $23.44 |
Low: | $22.62 |
Volume: | 614,248 |
Last Trade Date Time: | 04/18/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$22.71 | $22.87 | $23 | $23.44 | $22.62 | 614,248 | 04-18-2024 |
$23 | $23.52 | $23 | $23.54 | $22.76 | 957,823 | 04-17-2024 |
$23.39 | $23.02 | $23.39 | $23.65 | $22.76 | 714,294 | 04-16-2024 |
$23.15 | $23.5 | $23.15 | $23.63 | $22.91 | 724,423 | 04-15-2024 |
$23.51 | $23.66 | $23.51 | $23.82 | $23.31 | 426,853 | 04-12-2024 |
$23.82 | $24.01 | $23.82 | $24.1 | $23.39 | 569,115 | 04-11-2024 |
$23.8 | $24.72 | $23.8 | $24.72 | $23.19 | 818,119 | 04-10-2024 |
$25.46 | $24.32 | $25.46 | $25.64 | $24.25 | 855,619 | 04-09-2024 |
$24.23 | $25.5 | $24.23 | $25.5 | $24.01 | 952,848 | 04-08-2024 |
$25.2 | $25.08 | $25.2 | $25.37 | $24.86 | 723,284 | 04-05-2024 |
$25.05 | $25.83 | $25.05 | $26.01 | $25 | 776,691 | 04-04-2024 |
$25.65 | $25.26 | $25.65 | $25.68 | $25.09 | 569,606 | 04-03-2024 |
$25.36 | $25.27 | $25.36 | $25.38 | $24.88 | 1,032,571 | 04-02-2024 |
$25.74 | $24.95 | $25.74 | $26.1 | $24.94 | 838,044 | 04-01-2024 |
$25.19 | $25.43 | $25.19 | $25.69 | $25.19 | 845,312 | 03-29-2024 |
$25.19 | $25.43 | $25.19 | $25.69 | $25.19 | 845,312 | 03-28-2024 |
$25.32 | $24.89 | $25.32 | $25.36 | $24.59 | 746,707 | 03-27-2024 |
$24.75 | $24.88 | $24.75 | $25 | $24.45 | 567,961 | 03-26-2024 |
$24.66 | $24.74 | $24.66 | $24.83 | $24.14 | 853,655 | 03-25-2024 |
$24.5 | $24.88 | $24.5 | $24.88 | $24.23 | 747,069 | 03-22-2024 |
News, Short Squeeze, Breakout and More Instantly...
Corcept Therapeutics Incorporated Company Name:
CORT Stock Symbol:
NASDAQ Market:
MENLO PARK, Calif., April 15, 2024 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of th...
MENLO PARK, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of th...
MENLO PARK, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of th...